Review links acute, high-THC cannabis use with cardiovascular risks

High on the Heart? Cannabis Use and Cardiovascular Disease: A Systematic Review.

Journal of the American Heart Association • • Review • Highly Relevant
🤖

AI Summary

This systematic review examines how cannabis exposure relates to cardiovascular health, drawing on clinical evidence, epidemiological data, and biochemical mechanisms. It considers conditions including atherosclerosis, arrhythmias, heart failure, and stroke, and looks at whether cannabinoid composition, route of use, and frequency may shape outcomes.

The review reports that acute use and cannabis with a high Δ9-THC/CBD ratio are associated with increased risks of cardiovascular outcomes, particularly among younger people without known cardiovascular risk factors. The abstract provides no quantitative estimates, and the review cannot establish that cannabis causes these outcomes. It also calls for standardized ways to measure cannabis exposure; this is an abstract-based summary, not a review of the full text.

💡 Key Findings

1
Acute use and cannabis with a high Δ9-THC/CBD ratio are associated with increased cardiovascular risks, according to the review.
Good
65%
2
The reported association is especially noted among younger people without cardiovascular risk factors; the abstract does not provide quantitative risk estimates.
Good
65%
3
The review examines evidence on atherosclerosis, arrhythmias, heart failure, and stroke, but the abstract does not establish that cannabis causes these conditions.
High
90%
4
The authors identify standardized cannabis-exposure measures as a priority for future research to clarify cardiovascular risks.
High
90%

📄 Original Abstract

Cannabis use has increased substantially over the past 2 decades following shifts in public perception, legalization, and medical usage. Although neurological and psychiatric effects are well known, the cardiovascular effects of cannabis exposure are largely understudied. This review evaluates the cardiovascular effects of cannabis use by examining clinical evidence, epidemiological data, and underlying biochemical mechanisms. This review examines cannabis-related cardiovascular conditions, including atherosclerosis, arrhythmias, heart failure, and stroke. The analysis focused on cannabinoid composition, route of administration, frequency of use, and cardiovascular outcomes. Evidence indicates that acute and high Δ9-tetrahydrocannabinol/cannabidiol ratio cannabis use is associated with increased risks of various cardiovascular outcomes, especially among younger individuals without cardiovascular risk factors. Given rising use and increasing Δ9-tetrahydrocannabinol potency, clinicians must routinely assess cannabis exposure when evaluating cardiovascular disease, especially in younger patients. Future research must prioritize the development of standardized exposure metrics in cannabis-related cardiovascular disease research, thus allowing clinicians and patients to better understand the cardiovascular risks of cannabis use and initiate effective cessation strategies.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.